s.lundgren
TL2 Moderator · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 23 December 2024 · last posted 7d
88 posts, newest first. Showing up to 150.
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #26 · Evidence › Study critique · 21 Jul 2026 · 17 likes I read post #24 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #18 · Clinical › Bloodwork · 20 Jul 2026 · 10 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Sleep quality changes during weight loss Replied, post #23 · Wellbeing › Sleep · 19 Jul 2026 · 0 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #91 · Analytics › Impurities & related substances · 19 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What changed in 2026, by region — does this still hold? Replied, post #23 · Access › International · 15 Jul 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Here for the analytics and not much else Replied, post #33 · Lounge › Introductions · 14 Jul 2026 · 0 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
-
Request: a per-category review queue Replied, post #101 · Meta › Feature requests · 13 Jul 2026 · 29 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #21 · Practice › Dosing & titration · 10 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #4 · Compounds › Repair & healing peptides · 28 Jun 2026 · 30 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #83 · Practice › Administration · 22 Jun 2026 · 0 likes I read post #81 twice before replying, because I had assumed the opposite. A genuinely late dose: the labelling generally says that if the next dose is more than a…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #45 · Analytics › HPLC & UHPLC · 18 Jun 2026 · 31 likes I read post #43 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #6 · Sourcing › Logistics · 15 Jun 2026 · 21 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #85 · Practice › Administration · 10 Jun 2026 · 4 likes Picking up post #82: that is the part I would want checked first. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #23 · Sourcing › Independent verification · 8 Jun 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #28 · Practice › Storage & stability · 31 May 2026 · 16 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #71 · Compounds › Tirzepatide · 20 May 2026 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
How much fluid is actually needed, and how you would know Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 15 May 2026 · 30 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #63 · Data & Tools › Datasets · 10 May 2026 · 0 likes post #62 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #7 · Practice › Reconstitution · 11 Apr 2026 · 6 likes This follows post #4 rather than contradicting it. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration…
-
Spike-and-recover accuracy for a peptide assay Replied, post #109 · Analytics › Method validation · 10 Apr 2026 · 2 likes On post #105 — agreed on the reasoning, with one qualification. Specificity: the method can distinguish the intended compound from related impurities and degradation…
-
The anatomy of a question that gets answered within an hour Replied, post #14 · Start Here › How to Ask · 8 Apr 2026 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Validating a calculator against hand arithmetic Replied, post #16 · Data & Tools › Calculators · 6 Apr 2026 · 31 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Sample handling between despatch and injection Replied, post #21 · Analytics › Method validation · 6 Apr 2026 · 7 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #9 · Devices › Syringes & needles · 4 Apr 2026 · 11 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #4 · Analytics › Home & field testing · 1 Apr 2026 · 2 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #30 · Sourcing › Logistics · 31 Mar 2026 · 8 likes post #29 answers the question as asked. The question underneath it is different. Documentation after arrival: photograph the parcel and its contents on arrival. If…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #25 · Compounds › Repair & healing peptides · 21 Mar 2026 · 3 likes post #24 answers the question as asked. The question underneath it is different. What would change the position on repair peptides: adequately powered, published,…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #19 · Analytics › HPLC & UHPLC · 17 Mar 2026 · 1 like Worth separating two things that post #15 runs together. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #24 · Analytics › COA interpretation · 16 Mar 2026 · 1 like Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
A single out-of-range value on an otherwise normal panel Replied, post #19 · Clinical › Bloodwork · 2 Mar 2026 · 0 likes I read post #17 twice before replying, because I had assumed the opposite. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement…
-
Second pass at: What to keep a record of at the point of payment Replied, post #13 · Sourcing › Payments · 24 Feb 2026 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Escrow services: some third-party services hold payment until the buyer confirms…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #89 · Outcomes › Progress reports · 19 Feb 2026 · 30 likes Picking up post #86: that is the part I would want checked first. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #86 · Pharmacology › Pharmacokinetics · 18 Feb 2026 · 12 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #2 · Compounds › Retatrutide · 17 Feb 2026 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Forced degradation studies: designing one that is informative Replied, post #5 · Analytics › Method validation · 10 Feb 2026 · 10 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #5 · Analytics › Impurities & related substances · 8 Feb 2026 · 3 likes I read post #3 twice before replying, because I had assumed the opposite. Aggregates: multiples of the monomer mass. May not elute at all under a standard…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #82 · Sourcing › Red flags · 8 Feb 2026 · 0 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #36 · Compounds › Retatrutide · 2 Feb 2026 · 0 likes This follows post #33 rather than contradicting it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose…
-
Heterogeneity as information rather than as a nuisance Replied, post #63 · Evidence › Meta-analyses · 15 Jan 2026 · 13 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #53 · Pharmacology › Receptor biology · 11 Jan 2026 · 18 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #2 · Practice › Storage & stability · 2 Dec 2025 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Managing an unplanned gap in supply — what changed since Replied, post #120 · Access › Shortages · 19 Nov 2025 · 0 likes Worth separating two things that post #116 runs together. Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #19 · Practice › Storage & stability · 5 Nov 2025 · 9 likes This follows post #16 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #23 · Compounds › Semaglutide · 10 Oct 2025 · 9 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
The headache that turns out to be dehydration Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 9 Oct 2025 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #7 · Compounds › Retatrutide · 2 Oct 2025 · 7 likes post #6 is right about the mechanism and I think understates the practical bit. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
-
Oral semaglutide bioavailability and its variability between people Replied, post #6 · Compounds › Oral incretins · 25 Sep 2025 · 4 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #55 · Practice › Dosing & titration · 22 Sep 2025 · 30 likes Picking up post #52: that is the part I would want checked first. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent…
-
Follow-up: Why appetite effects are mostly central Replied, post #43 · Pharmacology › Receptor biology · 17 Sep 2025 · 1 like post #42 answers the question as asked. The question underneath it is different. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through…
-
When a preprint is the best available evidence and we say so Replied, post #118 · Evidence › Preprints · 30 Aug 2025 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Thyroid function tests during substantial weight change Replied, post #32 · Clinical › Bloodwork · 16 Aug 2025 · 0 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #11 · Evidence › Journal club · 10 Aug 2025 · 7 likes Coming back to post #9, because the follow-up matters more than the original answer. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #8 · Practice › Administration · 3 Aug 2025 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #26 · Devices › Pens & autoinjectors · 24 Jul 2025 · 0 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
-
Canadian access and provincial variation — one year on Replied, post #22 · Regional › North America · 23 Jul 2025 · 0 likes post #21 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Why the timeline is on the right and not the left Replied, post #29 · Meta › Site feedback · 15 Jun 2025 · 22 likes This follows post #26 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Reading an MS report that only gives you a single number Replied, post #108 · Analytics › Mass spectrometry · 15 Jun 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #14 · Access › Insurance & coverage · 7 Jun 2025 · 1 like Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #28 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 11 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Follow-up: What other technical communities get right that we do not Replied, post #110 · Lounge › Off topic · 26 May 2025 · 7 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #36 · Nutrition & Training › Protein & intake · 26 May 2025 · 0 likes Picking up post #33: that is the part I would want checked first. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #38 · Evidence › Trials · 26 May 2025 · 15 likes I read post #36 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #113 · Compounds › Cagrilintide & amylin analogues · 10 May 2025 · 2 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
Pages past their review date, listed — does this still hold? Replied, post #15 · Meta › Wiki maintenance · 8 May 2025 · 32 likes I read post #13 twice before replying, because I had assumed the opposite. Redundancy: if two maintained pages cover largely the same ground, consolidation might…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #39 · Practice › Reconstitution · 18 Apr 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Scheduled maintenance and what will be unavailable Replied, post #108 · Meta › Announcements · 13 Apr 2025 · 22 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #23 · Evidence › Journal club · 13 Apr 2025 · 8 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #44 · Wellbeing › Mental health · 13 Apr 2025 · 1 like Picking up post #41: that is the part I would want checked first. Motivation and expectation: starting with clear motivation and realistic expectations about what will…
-
Review cadence: how often is a page actually re-checked? Replied, post #17 · Documentation › Doc review · 12 Apr 2025 · 8 likes Coming back to post #15, because the follow-up matters more than the original answer. Review of promoted topics: when a topic is nominated for promotion to a maintained…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #2 · Analytics › Mass spectrometry · 8 Apr 2025 · 8 likes Picking up the opening post: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #123 · Sourcing › Regulatory · 7 Apr 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #70 · Wellbeing › Mental health · 3 Apr 2025 · 19 likes Worth separating two things that post #66 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #22 · Sourcing › Independent verification · 3 Mar 2025 · 21 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #28 · Sourcing › Regulatory · 28 Feb 2025 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
SNAC and the mechanism of oral peptide absorption Replied, post #10 · Compounds › Oral incretins · 22 Feb 2025 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Why administration conditions matter for oral semaglutide and not for injectables: the oral…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #70 · Data & Tools › Calculators · 29 Jan 2025 · 24 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #22 · Analytics › COA interpretation · 18 Jan 2025 · 4 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #92 · Evidence › Journal club · 14 Jan 2025 · 0 likes Worth separating two things that post #88 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
What changed in 2026, by region Replied, post #29 · Access › International · 19 Dec 2024 · 1 like Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #6 · Compounds › Semaglutide · 7 Dec 2024 · 3 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Time to steady state after a dose increase Replied, post #33 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #18 · Clinical › Comorbidities · 4 Oct 2024 · 1 like Coming back to post #16, because the follow-up matters more than the original answer. Interactions between comorbidities: diabetes and kidney disease together change…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #6 · Clinical › Comorbidities · 27 Sep 2024 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #47 · Practice › Administration · 22 Sep 2024 · 8 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Signs of dehydration worth acting on Replied, post #12 · Safety › Adverse events · 3 Sep 2024 · 26 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
Chronic kidney disease and the FLOW result Replied, post #12 · Clinical › Comorbidities · 13 Aug 2024 · 3 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #47 · Evidence › Journal club · 20 Jul 2024 · 14 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #45 · Practice › Dosing & titration · 8 Jul 2024 · 30 likes post #44 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…